3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
4
Stomach Neoplasms
3
Gastrointestinal Neoplasms
3
Rectal Neuroendocrine Tumors
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Small Size Gastrointestinal Stromal Tumors
1
Precancerous Conditions
1
Hemorrhage
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Polyps
1
Clinical Stage III Gastric Cancer AJCC v8
1
Benign Colon Tumors
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
6
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Endoscopic Mucosal Resection
×
1 year
×
Clear all
No trials found.